최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cancer gene therapy, v.15 no.5, 2008년, pp.331 - 340
Kim, K S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) , Lee, Y K (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) , Kim, J S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) , Koo, K H (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea) , Hong, H J (2Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea) , Park, Y S (1Department of Biomedical Laboratory Science, Institute of Health Science, Yonsei University, Wonju, Republic of Korea)
Anti-tumor-associated glycoprotein (TAG)-72 PEG-immunoliposomes (PILs) were prepared by conjugation of Fab′ fragments of recombinant humanized monoclonal antibody, HuCC49, to sterically stabilize unilamellar liposomes (90–110 nm in diameter) to target TAG-72-overexpressing cancer c...
Nat Rev Cancer F McCormick 1 130 2001 10.1038/35101008 McCormick F . Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 2001; 1: 130-141.
PL Felgner 26 1999 Non-Viral Vectors for Gene Therapy Felgner PL . Progress in gene delivery research and development. In: Huang L, Hung MC, Wagner E (eds). Non-Viral Vectors for Gene Therapy. Academic Press: San Diego, CA, 1999, pp 26-38.
Curr Opin Mol Ther KF Pirollo 2 168 2000 Pirollo KF, Xu L, Chang EH . Non-viral gene delivery for p53. Curr Opin Mol Ther 2000; 2: 168-175.
BioDrugs G Bendas 15 215 2001 10.2165/00063030-200115040-00002 Bendas G . Immunoliposomes: a promising approach to targeting cancer. BioDrugs 2001; 15: 215-224.
Curr Drug Deliv P Sapra 2 369 2005 10.2174/156720105774370159 Sapra P, Tyagi P, Allen TM . Ligand-targeted liposomes for cancer treatment. Curr Drug Deliv 2005; 2: 369-381.
J Pharm Sci K Maruyama 79 978 1990 10.1002/jps.2600791107 Maruyama K, Holmberg E, Kennel SJ, Klibanov A, Torchilin VP, Huang L . Characterization of in vivo immuno-liposome targeting to pulmonary endothelium. J Pharm Sci 1990; 79: 978-984.
Proc Natl Acad Sci USA D Aragnol 83 2699 1986 10.1073/pnas.83.8.2699 Aragnol D, Leserman LD . Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc Natl Acad Sci USA 1986; 83: 2699-2703.
Biochim Biophys Acta JTP Derksen 971 127 1988 Derksen JTP, Marselt HWM, Scherphof GL . Uptake and processing of immunoglobulin-coated liposomes by sub-populations of rat liver macrophages. Biochim Biophys Acta 1988; 971: 127-136.
Biochim Biophys Acta TM Allen 1066 29 1991 10.1016/0005-2736(91)90246-5 Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A . Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29-36.
Bioconjug Chem HS Kim 15 1095 2004 10.1021/bc049934t Kim HS, Moon J, Kim KS, Choi MM, Lee JE, Heo Y et al. Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chains. Bioconjug Chem 2004; 15: 1095-1101.
Hybridoma SVS Kashmiri 14 461 1995 10.1089/hyb.1995.14.461 Kashmiri SVS, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH . Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 1995; 14: 461-473.
FEBS Letters K Maruyama 413 177 1997 10.1016/S0014-5793(97)00905-8 Maruyama K, Takahashi N, Tagawa T, Nagaike K, Iwatsuru M . Immunoliposomes bearing polyethyleneglycol-coupled Fab′ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Letters 1997; 413: 177-180.
Cancer Res C Mamot 65 11631 2005 10.1158/0008-5472.CAN-05-1093 Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer. Cancer Res 2005; 65: 11631-11638.
Biosci Rep K Maruyama 22 251 2002 10.1023/A:1020138622686 Maruyama K . PEG-immunoliposome. Biosci Rep 2002; 22: 251-266.
Oncol Res KS Kim 15 343 2005 10.3727/096504005776449707 Kim KS, Park YS . Antitumor effects of angiostatin K 1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method. Oncol Res 2005; 15: 343-350.
Cancer Gene Ther KS Kim 13 563 2006 10.1038/sj.cgt.7700924 Kim KS, Kim DS, Chung KH, Park YS . Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes. Cancer Gene Ther 2006; 13: 563-571.
Cancer Gene Ther KS Kim 11 441 2004 10.1038/sj.cgt.7700716 Kim KS, Kim HS, Park JS, Kwon YG, Park YS . Inhibition of B16BL6 tumor progression by coadministration of recombinant angiostatin K1-3 and endostatin genes with cationic liposomes. Cancer Gene Ther 2004; 11: 441-449.
J Control Release HS Kim 115 234 2006 10.1016/j.jconrel.2006.08.003 Kim HS, Song IH, Kim JC, Kim EJ, Jang DO, Park YS . In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O′-dimyristyl-N-lysyl aspartate) and DMKE (O,O′-dimyristyl-N-lysyl glutamate). J Control Release 2006; 115: 234-241.
Proc Natl Acad Sci USA N Shi 97 7567 2000 10.1073/pnas.130187497 Shi N, Pardridge WM . Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 2000; 97: 7567-7572.
Mol Ther Y Zhang 6 67 2002 10.1006/mthe.2002.0633 Zhang Y, Zhu C, Pardridge WM . Antisense gene therapy of brain cancer with an artificial virus gene delivery system. Mol Ther 2002; 6: 67-72.
J Drug Target C Mamot 14 215 2006 10.1080/10611860600691049 Mamot C, Ritschard R, Kung W, Park JW, Herrmann R, Rochlitz CF . EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. J Drug Target 2006; 14: 215-223.
Mol Med L Xu 7 726 2001 10.1007/BF03401962 Xu L, Tang WH, Huang CC, Alexander W, Xiang LM, Pirollo KF et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001; 7: 726-738.
Am J Pathol N Weinder 147 9 1995 Weinder N . Intratumoral microvessle density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19.
Proc Natl Acad Sci USA HG Enoch 76 145 1979 10.1073/pnas.76.1.145 Enoch HG, Strittmatter P . Formation and properties of 1000- angstrom -diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci USA 1979; 76: 145-149.
Science E Marshall 286 2244 1999 10.1126/science.286.5448.2244 Marshall E . Gene therapy death prompts review of adenovirus vector. Science 1999; 286: 2244-2245.
E Wagner 208 1999 Non-Viral Vectors for Gene Therapy Wagner E . Ligand-polycation conjugates for receptor-targeted gene transfer. In: Huang L, Hung MC, Wagner E (eds). Non-Viral Vectors for Gene Therapy. Academic Press: San Diego, CA, 1999, pp 208-227.
Annu Rev Biomed Eng VP Torchilin 8 343 2006 10.1146/annurev.bioeng.8.061505.095735 Torchilin VP . Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 2006; 8: 343-735.
J Urol HN Keer 143 381 1990 10.1016/S0022-5347(17)39970-6 Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT . Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 1990; 143: 381-385.
Hum Gene Ther PW Cheng 7 275 1996 10.1089/hum.1996.7.3-275 Cheng PW . Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996; 7: 275-282.
Biochim Biophys Acta TM Allen 1237 99 1995 10.1016/0005-2736(95)00085-H Allen TM, Brandeis E, Hansen CB, Kao GY, Zalipsky S . A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim Biophys Acta 1995; 1237: 99-108.
Biochim Biophys Acta DL Iden 1513 207 2001 10.1016/S0005-2736(01)00357-1 Iden DL, Allen TM . In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 2001; 1513: 207-216.
Curr Opin Mol Ther DD Lasic 1 177 1999 Lasic DD, Vallner JJ, Working PK . Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther 1999; 1: 177-185.
Proc Natl Acad Sci USA JW Park 92 1327 1995 10.1073/pnas.92.5.1327 Park JW, Hong K, Carter P, Asgari H, Guo LY, Keller GA et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci USA 1995; 92: 1327-1331.
Cancer Lett C Brignolea 197 199 2003 10.1016/S0304-3835(03)00099-5 Brignolea C, Marimpietria D, Gambinib C, Allenc TM, Ponzonia M, Pastorino F . Development of Fab′ fragments of anti-GD2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma. Cancer Lett 2003; 197: 199-204.
Int J Pharm K Ng 193 157 2000 10.1016/S0378-5173(99)00330-0 Ng K, Zhao L, Liu Y, Mahapatro M . The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome. Int J Pharm 2000; 193: 157-166.
Ann N Y Acad Sci PL Felgner 772 126 1995 10.1111/j.1749-6632.1995.tb44738.x Felgner PL, Tsai YJ, Sukhu L, Wheeler CJ, Manthorpe M, Marshall J et al. Improved cationic lipid formulations for in vivo gene therapy. Ann N Y Acad Sci 1995; 772: 126-139.
Biochem Biophys Res Commun NK Egilmez 40 169 1996 10.1006/bbrc.1996.0564 Egilmez NK, Iwanuma Y, Bankert RB . Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. Biochem Biophys Res Commun 1996; 40: 169-173.
Hum Gene Ther RI Mahato 9 2083 1998 10.1089/hum.1998.9.14-2083 Mahato RI, Anwer K, Tagliaferri F, Meaney C, Leonard P, Wadhwa MS et al. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther 1998; 9: 2083-2099.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.